These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 2535301

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62. Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series.
    Malliotakis P, Xenikakis T, Linardakis M, Hassoulas J.
    Hellenic J Cardiol; 2007; 48(2):80-8. PubMed ID: 17489345
    [Abstract] [Full Text] [Related]

  • 63. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure.
    Weber KT, Janicki JS, Jain MC.
    J Heart Transplant; 1986; 5(2):105-12. PubMed ID: 2956397
    [Abstract] [Full Text] [Related]

  • 64. Levosimendan compared with dobutamine in low output patients.
    Nieminen MS.
    Minerva Anestesiol; 2003 Apr; 69(4):258-63. PubMed ID: 12766717
    [Abstract] [Full Text] [Related]

  • 65. The role of enoximone in the treatment of cardiogenic shock.
    Vincent JL, Léon M, Berré J.
    Cardiology; 1990 Apr; 77 Suppl 3():21-6; discussion 27-33. PubMed ID: 2176130
    [Abstract] [Full Text] [Related]

  • 66. Comparison of the haemodynamic effects of enoximone and piroximone in patients after cardiac surgery.
    Patel A, Caldicott LD, Skoyles JR, Das P, Sherry KM.
    Br J Anaesth; 1993 Dec; 71(6):869-72. PubMed ID: 8280556
    [Abstract] [Full Text] [Related]

  • 67. [Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery].
    Alvarez J, Bouzada M, Fernández AL, Caruezo V, Taboada M, Rodríguez J, Ginesta V, Rubio J, García-Bengoechea JB, González-Juanatey JR.
    Rev Esp Cardiol; 2006 Apr; 59(4):338-45. PubMed ID: 16709386
    [Abstract] [Full Text] [Related]

  • 68. [Enoximone in the treatment of postoperative low cardiac output syndrome in pediatric heart surgery. Open study in tetralogy of Fallot].
    Cossolini M, Ferri F, Giupponi A, Valoti O, Veritti U.
    Minerva Anestesiol; 1997 Jun; 63(6):213-9. PubMed ID: 9411285
    [Abstract] [Full Text] [Related]

  • 69. Relation between mixed venous oxygen saturation and cardiac index. Nonlinearity and normalization for oxygen uptake and hemoglobin.
    Jain A, Shroff SG, Janicki JS, Reddy HK, Weber KT.
    Chest; 1991 Jun; 99(6):1403-9. PubMed ID: 1828020
    [Abstract] [Full Text] [Related]

  • 70. Myocardial energetics and clinical response to the cardiotonic agent MDL 17043 in advanced heart failure.
    Martin JL, Likoff MJ, Janicki JS, Laskey WK, Hirshfeld JW, Weber KT.
    J Am Coll Cardiol; 1984 Nov; 4(5):875-83. PubMed ID: 6238075
    [Abstract] [Full Text] [Related]

  • 71. [Treatment of low cardiac output syndrome in newborn infants and children].
    Hausdorf G, Loebe M.
    Z Kardiol; 1994 Nov; 83 Suppl 2():91-100. PubMed ID: 8091831
    [Abstract] [Full Text] [Related]

  • 72. Amrinone and dobutamine as primary treatment of low cardiac output syndrome following coronary artery surgery: a comparison of their effects on hemodynamics and outcome.
    Dupuis JY, Bondy R, Cattran C, Nathan HJ, Wynands JE.
    J Cardiothorac Vasc Anesth; 1992 Oct; 6(5):542-53. PubMed ID: 1421065
    [Abstract] [Full Text] [Related]

  • 73. Use of inotropes in the critical care setting.
    Löllgen H, Drexler H.
    Crit Care Med; 1990 Jan; 18(1 Pt 2):S56-60. PubMed ID: 2136722
    [Abstract] [Full Text] [Related]

  • 74. Pharmacologic and hemodynamic effects of combined beta-agonist stimulation and phosphodiesterase inhibition in the failing human heart.
    Gilbert EM, Hershberger RE, Wiechmann RJ, Movsesian MA, Bristow MR.
    Chest; 1995 Dec; 108(6):1524-32. PubMed ID: 7497755
    [Abstract] [Full Text] [Related]

  • 75. Treatment of heart failure with enoximone, a new phosphodiesterase inhibitor. Düsseldorf, Federal Republic of Germany. September 25-27, 1987. Proceedings.
    J Cardiovasc Pharmacol; 1989 Dec; 14 Suppl 1():S1-S83. PubMed ID: 2480479
    [No Abstract] [Full Text] [Related]

  • 76. Antiischemic and hemodynamic effects of an oral single dose of 150 mg of the phosphodiesterase inhibitor enoximone in patients with coronary artery disease--relation to plasma concentration.
    Mitrovic V, Petrovic O, Bahavar H, Neuzner J, Dieterich HA, Schlepper M.
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):689-95. PubMed ID: 1832289
    [Abstract] [Full Text] [Related]

  • 77. Comparison of the effects of amrinone and dobutamine on hemodynamics and myocardial oxygen balance in dogs with experimental left ventricular failure.
    Fujigaki T, Nakamura H, Fukui S, Miyako M, Haseba S, Gotoh Y.
    J Cardiothorac Anesth; 1989 Aug; 3(4):433-40. PubMed ID: 2520916
    [Abstract] [Full Text] [Related]

  • 78. [Enoximone].
    Ventura G.
    Medicina (Firenze); 1990 Aug; 10(2):191-3. PubMed ID: 2148796
    [Abstract] [Full Text] [Related]

  • 79. Amrinone in the management of low cardiac output after open heart surgery.
    Goenen M, Pedemonte O, Baele P, Col J.
    Am J Cardiol; 1985 Jul 22; 56(3):33B-38B. PubMed ID: 4025158
    [Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.